It was the first time since 2012 that AbbVie's rheumatoid arthritis biologic Humira didn't top the list of hospitals' highest drug expenditures.

Join The Ecosystem

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}